These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 19307463)
1. Modulation of iron-regulatory genes in human hepatocellular carcinoma and its physiological consequences. Tan MG; Kumarasinghe MP; Wang SM; Ooi LL; Aw SE; Hui KM Exp Biol Med (Maywood); 2009 Jun; 234(6):693-702. PubMed ID: 19307463 [TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Murakami Y; Yasuda T; Saigo K; Urashima T; Toyoda H; Okanoue T; Shimotohno K Oncogene; 2006 Apr; 25(17):2537-45. PubMed ID: 16331254 [TBL] [Abstract][Full Text] [Related]
3. Role of transferrin receptor 2 in hepatic accumulation of iron in patients with chronic hepatitis C. Mifuji R; Kobayashi Y; Ma N; Qiang QL; Urawa N; Horiike S; Iwasa M; Kaito M; Malavasi F; Adachi Y J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):144-51. PubMed ID: 16706826 [TBL] [Abstract][Full Text] [Related]
4. Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver. Masaki T; Tokuda M; Yoshida S; Nakai S; Morishita A; Uchida N; Funaki T; Kita Y; Funakoshi F; Nonomura T; Himoto T; Deguchi A; Kimura Y; Izuishi K; Wakabayashi H; Usuki H; Yoshiji H; Watanabe S; Kurokohchi K; Kuriyama S Int J Oncol; 2005 Mar; 26(3):661-71. PubMed ID: 15703821 [TBL] [Abstract][Full Text] [Related]
5. Expression of cell cycle/growth regulator genes in human hepatocellular carcinoma and adjacent normal liver tissues. Liu LX; Jiang HC; Liu ZH; Zhu AL; Zhang WH; Wu LF; Zhou J; Wang XQ; Wu M Oncol Rep; 2003; 10(6):1771-5. PubMed ID: 14534694 [TBL] [Abstract][Full Text] [Related]
6. Fas / FasL system, IL-1beta expression and apoptosis in chronic HBV and HCV liver disease. Bortolami M; Kotsafti A; Cardin R; Farinati F J Viral Hepat; 2008 Jul; 15(7):515-22. PubMed ID: 18331250 [TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags. Yoon SY; Kim JM; Oh JH; Jeon YJ; Lee DS; Kim JH; Choi JY; Ahn BM; Kim S; Yoo HS; Kim YS; Kim NS Int J Oncol; 2006 Aug; 29(2):315-27. PubMed ID: 16820872 [TBL] [Abstract][Full Text] [Related]
8. Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma. Mohammad HS; Kurokohchi K; Yoneyama H; Tokuda M; Morishita A; Jian G; Shi L; Murota M; Tani J; Kato K; Miyoshi H; Deguchi A; Himoto T; Usuki H; Wakabayashi H; Izuishi K; Suzuki Y; Iwama H; Deguchi K; Uchida N; Sabet EA; Arafa UA; Hassan AT; El-Sayed AA; Masaki T Int J Oncol; 2008 Dec; 33(6):1157-63. PubMed ID: 19020748 [TBL] [Abstract][Full Text] [Related]
9. High expression of vanilloid receptor-1 is associated with better prognosis of patients with hepatocellular carcinoma. Miao X; Liu G; Xu X; Xie C; Sun F; Yang Y; Zhang T; Hua S; Fan W; Li Q; Huang S; Wang Q; Liu G; Zhong D Cancer Genet Cytogenet; 2008 Oct; 186(1):25-32. PubMed ID: 18786439 [TBL] [Abstract][Full Text] [Related]
10. [Expression of two types of melanoma antigens in hepatocellular carcinoma]. Cai S; Leng X; Wang Y Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):205-7. PubMed ID: 11783086 [TBL] [Abstract][Full Text] [Related]
11. Enhanced expression of S8, L12, L23a, L27 and L30 ribosomal protein mRNAs in human hepatocellular carcinoma. Kondoh N; Shuda M; Tanaka K; Wakatsuki T; Hada A; Yamamoto M Anticancer Res; 2001; 21(4A):2429-33. PubMed ID: 11724303 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. Wong QW; Lung RW; Law PT; Lai PB; Chan KY; To KF; Wong N Gastroenterology; 2008 Jul; 135(1):257-69. PubMed ID: 18555017 [TBL] [Abstract][Full Text] [Related]
13. Different expression of apoptotic proteins between HBV-infected and non-HBV-infected hepatocellular carcinoma. Chang CS; Huang SM; Lin HH; Wu CC; Wang CJ Hepatogastroenterology; 2007; 54(79):2061-8. PubMed ID: 18251160 [TBL] [Abstract][Full Text] [Related]
14. Bcl-2 positivity in B and C hepatitis and hepatocellular carcinomas. Yildiz L; Baris S; Aydin O; Kefeli M; Kandemir B Hepatogastroenterology; 2008; 55(88):2207-10. PubMed ID: 19260506 [TBL] [Abstract][Full Text] [Related]
15. Transferrin and transferrin receptor gene expression and iron uptake in hepatocellular carcinoma in the rat. Pascale RM; De Miglio MR; Muroni MR; Simile MM; Daino L; Seddaiu MA; Pusceddu S; Gaspa L; Calvisi D; Manenti G; Feo F Hepatology; 1998 Feb; 27(2):452-61. PubMed ID: 9462644 [TBL] [Abstract][Full Text] [Related]
16. Upregulation of transferrin receptor 2 and ferroportin 1 mRNA in the liver of patients with chronic hepatitis C. Takeo M; Kobayashi Y; Fujita N; Urawa N; Iwasa M; Horiike S; Tanaka H; Kaito M; Adachi Y J Gastroenterol Hepatol; 2005 Apr; 20(4):562-9. PubMed ID: 15836704 [TBL] [Abstract][Full Text] [Related]
17. Correlation between expression of cyclooxygenase-2 and the presence of CD4+ infiltrating T-lymphocyte in human primary hepatocellular carcinoma. Gao YW; Chen YX; Wang ZM; Zhou LD; Li XY; Li LX; Luo QZ; Tian W; Fu CY; Zhou JH Hepatogastroenterology; 2008; 55(82-83):345-50. PubMed ID: 18613363 [TBL] [Abstract][Full Text] [Related]